Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
IMPACT
Evaluation of Safety and Efficacy of a Resorbable Collagen Implant in Treatment of High Grade PArtial ThiCkness Tears; A Prospective, Multicenter, Randomized, Control Trial (IMPACT Study)
1 other identifier
interventional
234
6 countries
20
Brief Summary
The purpose of the study is to assess whether the REGENETEN™ Bioinductive Implant allows patients to get back to their everyday activities quicker than if the tendon is repaired by the standard repair technique 'Completion and Repair' for surgically treating partial-thickness rotator cuff tears.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2022
Longer than P75 for not_applicable
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2022
CompletedFirst Posted
Study publicly available on registry
July 6, 2022
CompletedStudy Start
First participant enrolled
August 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
January 15, 2026
December 1, 2025
4 years
June 29, 2022
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Western Ontario Rotator Cuff (WORC)
The WORC Index is self-administered, and includes a 5 different domains (physical symptoms, sports and recreation, work, social function, and emotions). Each question uses a visual analog scale (VAS) representing a 100-point scale ranging from 0 to 100. The maximum score is 2100 (worst possible symptoms). Zero (0) represents no symptoms at all. The final score can also be presented as a percentage by subtracting the total from 2100, dividing by 2100, and multiplying by 100. This will give you an overall percentage. The total final WORC Index scores can, therefore, range from 0% (lowest functional status level) to 100% (highest functional status level).
Change from baseline to 3 months post-intervention
Secondary Outcomes (25)
Western Ontario Rotator Cuff (WORC)
Pre-op, 6 weeks, 3, 6, 12 and 24 months
Constant-Murley Score
Pre-Op, 3, 6, 12 and 24 months
Subjective Shoulder Value (SSV) score
Pre-Op, 6 weeks, 3, 12 and 24 months
EuroQol 5 Dimension 5 Level (EQ-5D-5L) VAS & index scores
Pre-Op, 3 and 6 weeks, 3, 6, 12 and 24 months
Change in Western Ontario Rotator Cuff (WORC)
Change from Pre-op to 6 weeks, 3, 6, 12 and 24 months
- +20 more secondary outcomes
Study Arms (2)
Isolated Bioinductive Repair
EXPERIMENTALSurgical treatment of partial-thickness rotator cuff tears with the REGENETEN Bioinductive Implant system.
Completion and Repair
ACTIVE COMPARATORSurgical treatment of partial-thickness rotator cuff tears using the standard surgical technique 'Completion and Repair'.
Interventions
Isolated Bioinductive repair with REGENETEN™ Bioinductive Implant
Standard surgical repair using the 'Completion and Repair' technique.
Eligibility Criteria
You may qualify if:
- The subject must provide written informed consent.
- Subject is \> eighteen (18) years of age (no upper limit).
- Subject has an isolated high-grade (\>50% or \>6mm) (Ellman grade III) partial thickness tear of supraspinatus or supraspinatus with infraspinatus.
- Subject has failed a minimum of 3 months of conservative management for treatment of partial thickness rotator cuff tear.
- Subject willing and able to make all required study visits.
- Subject able to follow instructions and deemed capable of completing all study questionnaires.
You may not qualify if:
- Subjects with insufficient tendon tissue quality for management and protection of the tendon injury using the isolated REGENETEN Bioinductive Implant system.
- Subjects where the prescribed Physical Therapy guidelines stated in the protocol are not suitable for their rehabilitation.
- Subjects with Samilson-Prieto osteoarthritis grade 2 and greater.
- Subjects with current or prior infection of the ipsilateral shoulder.
- Subjects with known hypersensitivity to bovine-derived materials.
- Subjects with known inflammatory arthropathy, history of inflammatory arthropathy, chronic joint disease or chronic pain of upper extremities (shoulder(s), arm(s)).
- Subjects with prior shoulder surgery on index shoulder, including subacromial decompression, biceps tenodesis/tenotomy, and acromioclavicular joint (ACJ) excision/distal clavicle excision (DCE).
- Subjects with a planned surgery on the contra-lateral shoulder within the study period.
- Systemic steroid use (oral, IV) or local steroid injection within 3 months of the date of surgery.
- Subjects with a full thickness rotator cuff tear.
- Subjects with a subscapularis tear requiring repair.
- Subjects requiring a concomitant labral fixation procedure, concomitant surgery for bone defects requiring bone implantation or for superior labral tear from anterior to posterior (SLAP).
- Subjects requiring a concomitant os acromiale fixation procedure.
- Subjects with glenohumeral joint instability (multiple dislocations/subluxations).
- Subjects with condition(s) that contraindicate or complicate outcomes of Isolated Bioinductive Repair or completion and repair e.g., \> Hamada 3 rotator cuff arthropathy on X-ray, Goutallier atrophy \> Grade 3, proximal humeral fracture or scapular fracture, avascular necrosis of the humeral head.
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (20)
Harbin Clinic
Rome, Georgia, 30165, United States
OrthoIllinois LTD
Rockford, Illinois, 61107, United States
Sinai Hospital Baltimore
Baltimore, Maryland, 21215, United States
Cleveland Clinic - Sports Health
Garfield Heights, Ohio, 44125, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Texas Orthopedic Specialists
Bedford, Texas, 76021, United States
Houston Methodist The Woodlands
The Woodlands, Texas, 77385, United States
Memorial Medical Center
Ashland, Wisconsin, 54806, United States
OrthoSport Victoria
Richmond, Victoria, 3121, Australia
Access Orthopaedics
Calgary, Alberta, T2R 2G5, Canada
Pan Am Clinic
Winnipeg, Manitoba, Canada
Research St. Joseph's
Hamilton, Ontario, Canada
IRCCS Istituto Ortopedico Galeazzi,
Milan, Italy
Fondazione Policlinico Universitario Campus Bio-Medico
Roma, Italy
Hospital Ramón y Cajal
Madrid, 28034, Spain
Hospital Fundación Jiménez Díaz
Madrid, 28040, Spain
Ashford & St Peter's Hospitals NHS Foundation Trust
Chertsey, Surrey, KT16 0PZ, United Kingdom
Sulis Hospital
Bath, United Kingdom
North Bristol NHS Trust
Bristol, United Kingdom
Northern Care Alliance NHS Foundation Trust
Salford, M6 8HD, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Laura Mills
Smith & Nephew, Inc.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2022
First Posted
July 6, 2022
Study Start
August 30, 2022
Primary Completion (Estimated)
August 15, 2026
Study Completion (Estimated)
June 30, 2028
Last Updated
January 15, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share